CVR number 27380190
Industry 75.0000 Veterinary activities

VetFamily Gentofte Dyreklinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.1% 8.3% 5.3% 5.3% 4.9%  
Credit score (0-100)  49 28 41 41 44  
Credit rating  BBB BB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  12,794 0 0 0 0  
Gross profit  8,038 10,280 11,963 13,813 15,576  
EBITDA  2,893 3,190 5,767 7,191 8,842  
EBIT  2,444 2,756 5,552 7,021 8,736  
Pre-tax profit (PTP)  2,423.9 2,724.8 5,515.6 7,040.6 8,931.4  
Net earnings  1,886.0 2,128.1 4,297.7 5,491.2 6,952.9  
Pre-tax profit without non-rec. items  2,424 2,725 5,516 7,041 8,931  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  1,181 878 336 254 614  
Shareholders equity total  2,094 2,423 4,485 5,726 7,679  
Interest-bearing liabilities  0.0 0.0 8.0 9.7 7.5  
Balance sheet total (assets)  4,577 4,204 7,020 9,061 11,408  
Net Debt  -1,421 -1,922 -5,669 -1,624 -1,411  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  12,794 0 0 0 0  
Net sales growth  18.8% -100.0% 0.0% 0.0% 0.0%  
Gross profit  8,038 10,280 11,963 13,813 15,576  
Gross profit growth  23.7% 27.9% 16.4% 15.5% 12.8%  
Employees  20 18 17 17 17  
Employee growth %  66.7% -10.0% -5.6% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,577 4,204 7,020 9,061 11,408  
Balance sheet change%  61.3% -8.1% 67.0% 29.1% 25.9%  
Added value  2,893.4 3,190.1 5,767.0 7,236.3 8,842.4  
Added value %  22.6% 0.0% 0.0% 0.0% 0.0%  
Investments  -609 -736 -757 -252 380  
Net sales trend  4.0 -1.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  22.6% 0.0% 0.0% 0.0% 0.0%  
EBIT %  19.1% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  30.4% 26.8% 46.4% 50.8% 56.1%  
Net Earnings %  14.7% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  18.3% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  18.9% 0.0% 0.0% 0.0% 0.0%  
ROA %  65.9% 62.8% 98.9% 87.6% 87.3%  
ROI %  122.8% 120.6% 159.6% 137.4% 133.1%  
ROE %  96.6% 94.2% 124.4% 107.5% 103.7%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  45.8% 57.6% 63.9% 63.2% 67.3%  
Relative indebtedness %  19.1% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  8.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -49.1% -60.3% -98.3% -22.6% -16.0%  
Gearing %  0.0% 0.0% 0.2% 0.2% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 905.6% 6.9% 29.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.2 1.5 2.3 2.4 2.6  
Current Ratio  1.4 1.7 2.6 2.6 2.8  
Cash and cash equivalent  1,420.9 1,922.1 5,677.0 1,633.8 1,418.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  2.3 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  113.2 0.0 0.0 0.0 0.0  
Current assets / Net sales %  24.7% 0.0% 0.0% 0.0% 0.0%  
Net working capital  866.4 1,321.3 3,907.0 5,207.5 6,673.3  
Net working capital %  6.8% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  640 0 0 0 0  
Added value / employee  145 177 339 426 520  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  145 177 339 423 520  
EBIT / employee  122 153 327 413 514  
Net earnings / employee  94 118 253 323 409